Terms: = Bone cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Diagnosis
454 results:
1. Myelodysplastic Neoplasms (mds): The Current and Future Treatment Landscape.
Karel D; Valburg C; Woddor N; Nava VE; Aggarwal A
Curr Oncol; 2024 Apr; 31(4):1971-1993. PubMed ID: 38668051
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms.
Lee WH; Lin CC; Tsai CH; Tien FM; Lo MY; Tseng MH; Kuo YY; Yu SC; Liu MC; Yuan CT; Yang YT; Chuang MK; Ko BS; Tang JL; Sun HI; Chuang YK; Tien HF; Hou HA; Chou WC
Blood Cancer J; 2024 Apr; 14(1):57. PubMed ID: 38594285
[TBL] [Abstract] [Full Text] [Related]
3. Myelodysplastic Syndromes and Myelodysplastic Syndromes/Myeloproliferative Neoplasms: A Real-World Experience From a Developing Country.
Awidi A; Alzu'bi M; Odeh N; Alrawabdeh J; Al Zyoud M; Hamadneh Y; Bawa'neh H; Magableh A; Alshorman A; Al-Fararjeh F; Aladily T; Zeidan AM
JCO Glob Oncol; 2024 Feb; 10():e2300281. PubMed ID: 38422464
[TBL] [Abstract] [Full Text] [Related]
4. [bone marrow histology of cytopenias : Contribution to hematological differential diagnosis].
Kreipe H
Pathologie (Heidelb); 2024 Mar; 45(2):148-158. PubMed ID: 38381371
[TBL] [Abstract] [Full Text] [Related]
5. Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope.
Elghetany MT; Patnaik MM; Khoury JD
Leuk Res; 2024 Feb; 137():107441. PubMed ID: 38301422
[TBL] [Abstract] [Full Text] [Related]
6. Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy.
Campillo-Marcos I; Casado-Pelaez M; Davalos V; Ferrer G; Mata C; Mereu E; Roué G; Valcárcel D; Molero A; Zamora L; Xicoy B; Palomo L; Acha P; Manzanares A; Tobiasson M; Hellström-Lindberg E; Solé F; Esteller M
Cancer Res Commun; 2024 Feb; 4(2):365-377. PubMed ID: 38300528
[TBL] [Abstract] [Full Text] [Related]
7. Case report of a patient with VEXAS syndrome.
Tsourveloudis I; Georgiadi EC; Vatalis G; Kotsi P
Medicine (Baltimore); 2023 Dec; 102(52):e36738. PubMed ID: 38206689
[TBL] [Abstract] [Full Text] [Related]
8. Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Nabergoj M; Eikema DJ; Koster L; Platzbecker U; Sockel K; Finke J; Kröger N; Forcade E; Nagler A; Eder M; Tischer J; Broers AEC; Kuball J; Wilson KMO; Hunault-Berger M; Collin M; Russo D; Corral LL; Helbig G; Mussetti A; Scheid C; Gurnari C; Raj K; Drozd-Sokolowska J; Yakoub-Agha I; Robin M; McLornan DP
Bone Marrow Transplant; 2024 Mar; 59(3):395-402. PubMed ID: 38195984
[TBL] [Abstract] [Full Text] [Related]
9. Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study.
Cargo C; Bernard E; Beinortas T; Bolton KL; Glover P; Warren H; Payne D; Ali R; Khan A; Short M; Van Hoppe S; Smith A; Taylor J; Evans P; Papaemmanuil E; Crouch S
Lancet Haematol; 2024 Jan; 11(1):e51-e61. PubMed ID: 38135373
[TBL] [Abstract] [Full Text] [Related]
10. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.
Sobas M; Knopinska-Posluszny W; Piątkowska-Jakubas B; García-Álvarez F; Díez MEA; Caballero M; Martínez-Cuadrón D; Aguiar E; González-Campos J; Garrido A; Algarra L; Salamero O; de la Serna J; Sayas MJ; Perez-Encinas MM; Vives S; Vidriales B; Labrador J; Prado AI; Celebrin L; Mayer J; Brioso J; de Laiglesia A; Bergua JM; Amigo ML; Rodriguez-Medina C; Polo M; Pluta A; Cichocka E; Skarupski M; Sanz MA; Wierzbowska A; Montesinos P
Ann Hematol; 2024 Feb; 103(2):451-461. PubMed ID: 38110588
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Gurnari C; Pascale MR; Vitale A; Diral E; Tomelleri A; Galossi E; Falconi G; Bruno A; Crisafulli F; Frassi M; Cattaneo C; Bertoli D; Bernardi M; Condorelli A; Morsia E; Poloni A; Crisà E; Caravelli D; Triggianese P; Brussino L; Battipaglia G; Bindoli S; Sfriso P; Caroni F; Dragani M; Mallegni F; Pilo F; Firinu D; Curti A; Papayannidis C; Olivieri A; Kordasti S; Albano F; Pane F; Musto P; Bocchia M; Lugli E; Breccia M; Frigeni M; Dagna L; Greco R; Franceschini F; Campochiaro C; Cantarini L; Voso MT
Am J Hematol; 2024 Feb; 99(2):254-262. PubMed ID: 38108611
[TBL] [Abstract] [Full Text] [Related]
12. Cytogenetics and molecular genetics of myelodysplastic neoplasms.
Ning Y; Zhang Y; Kallen MA; Emadi A; Baer MR
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101512. PubMed ID: 38092472
[TBL] [Abstract] [Full Text] [Related]
13. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, mds): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH).
Auger N; Douet-Guilbert N; Quessada J; Theisen O; Lafage-Pochitaloff M; Troadec MB
Curr Res Transl Med; 2023; 71(4):103409. PubMed ID: 38091642
[TBL] [Abstract] [Full Text] [Related]
14. Unlocking the Potential of Artificial Intelligence in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Alhajahjeh A; Nazha A
Curr Hematol Malig Rep; 2024 Feb; 19(1):9-17. PubMed ID: 37999872
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic work-up of hematological malignancies with underlying germline predisposition disorders (GPD).
Kanagal-Shamanna R; Schafernak KT; Calvo KR
Semin Diagn Pathol; 2023 Nov; 40(6):443-456. PubMed ID: 37977953
[TBL] [Abstract] [Full Text] [Related]
16. CDC-NET: a cell detection and confirmation network of bone marrow aspirate images for the aided diagnosis of AML.
Su J; Liu Y; Zhang J; Han J; Song J
Med Biol Eng Comput; 2024 Feb; 62(2):575-589. PubMed ID: 37953336
[TBL] [Abstract] [Full Text] [Related]
17. CD72 is a pan-tumor antigen associated to pediatric acute leukemia.
Buldini B; Faggin G; Porcù E; Scarparo P; Polato K; Tregnago C; Varotto E; Rizzardi P; Rizzari C; Locatelli F; Biffi A; Pigazzi M
Cytometry A; 2023 Dec; 103(12):1004-1009. PubMed ID: 37876342
[TBL] [Abstract] [Full Text] [Related]
18. Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists.
Madanat YF; Zeidan AM
Clin Lab Med; 2023 Dec; 43(4):685-698. PubMed ID: 37865511
[TBL] [Abstract] [Full Text] [Related]
19. Morphologic Characteristics of Myelodysplastic Syndromes.
Yuen LD; Hasserjian RP
Clin Lab Med; 2023 Dec; 43(4):577-596. PubMed ID: 37865504
[TBL] [Abstract] [Full Text] [Related]
20. [Current state of treatment for myelodysplastic syndromes].
Ichikawa M
Rinsho Ketsueki; 2023; 64(9):988-997. PubMed ID: 37793875
[TBL] [Abstract] [Full Text] [Related]
[Next]